afdx 384 has been researched along with scopolamine hydrobromide in 4 studies
| Studies (afdx 384) | Trials (afdx 384) | Recent Studies (post-2010) (afdx 384) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 78 | 0 | 6 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | afdx 384 (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pepeu, G; Vannucchi, MG | 1 |
| Aubert, I; Doods, H; Meaney, MJ; Parent, A; Quirion, R; Richard, J; Rowe, W; White, N; Wilson, A | 1 |
| Casamenti, F; Kopf, SR; Pepeu, G; Scali, C; Vannucchi, MG | 1 |
| Abitbol, M; Ascher, P; Baud, F; Bernard, V; Cendelin, J; Farar, V; Fournet, V; Houze, P; Hrabovska, A; Klein, J; Krejci, E; Lamotte d'Incamps, B; Legrand, M; Leroy, J; Mohr, F; Myslivecek, J; Plaud, B; Tuma, J; Zimmermann, M | 1 |
4 other study(ies) available for afdx 384 and scopolamine hydrobromide
| Article | Year |
|---|---|
Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus.
Topics: Acetylcholine; Animals; Cerebral Cortex; Diamines; Hippocampus; Male; Muscarinic Antagonists; Parasympatholytics; Pirenzepine; Rats; Rats, Wistar; Receptors, Muscarinic; Scopolamine | 1995 |
Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired.
Topics: Acetylcholine; Aging; Animals; Cognition; Dibenzazepines; Male; Maze Learning; Memory Disorders; Muscarinic Antagonists; Parasympatholytics; Pirenzepine; Pyridines; Rats; Rats, Inbred Strains; Scopolamine | 1995 |
Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats.
Topics: Acetylcholine; Aging; Animals; Cerebral Cortex; Male; Memory; Parasympatholytics; Pirenzepine; Rats; Rats, Wistar; Scopolamine; Task Performance and Analysis | 1997 |
Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase.
Topics: Acetylcholine; Acetylcholinesterase; Adaptation, Physiological; Animals; Animals, Newborn; Body Temperature; Brain; Bridged Bicyclo Compounds, Heterocyclic; Bungarotoxins; Choline; Cholinergic Agents; Cholinesterase Inhibitors; Collagen; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Exploratory Behavior; Gait; Gene Expression Regulation; In Vitro Techniques; Maze Learning; Membrane Potentials; Membrane Proteins; Mice; Mice, Knockout; Microdialysis; Motor Activity; Muscarinic Antagonists; Muscle Proteins; Nails, Ingrown; Neostigmine; Nerve Tissue Proteins; Neurons; Pirenzepine; Protein Binding; Pyridines; Radioisotopes; Receptors, Muscarinic; Rotarod Performance Test; Scopolamine; Spinal Cord; Statistics, Nonparametric; Tritium | 2012 |